Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Suzetrigine for Treatment and Reduction of Intense Discomfort After knEe Replacement PAIN [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Suzetrigine for treatment and reduction of postoperative pain after total knee replacement; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suzetrigine (Suzetrigine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Total Knee Replacement Surgery, Post-operative Pain | Phase 3 | Status: RECRUITING